Terutroban Versus Aspirin in Patients With Cerebral Ischaemic Events (PERFORM): A Randomised, Double-Blind, Parallel-Group Trial

Study Questions:

What is the safety and efficacy of terutroban (thromboxane-prostaglandin receptor antagonist) compared with aspirin in the prevention of cerebral and cardiovascular ischemic events in patients with a recent noncardioembolic cerebral ischemic event?